Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2014, Vol. 34 Issue (9): 108-112    DOI: 10.13523/j.cb.20140916
    
Advances on Bacterial Ghost as Novel Vaccine and Delivery Vector
YANG Hui, JIAO Hong-mei
Medical College of Yangzhou University, Yangzhou 225001, China
Download: HTML   PDF(383KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Bacterial ghost (BG) is an empty bacterial envelope of gram-negative bacteria devoid of cytoplasmic content,and produced by controlled expression of bacteriophage PhiX174 lysis gene E. BG keeps intact bacterial outer membrane structure, such as flagella, LPS and outer membrane proteins, making bacterial easy to adherence to the human or animal cell receptors, so it can be used as vaccines without adjuvant to induce strong humoral immune response and cellular immune response. BG has many spaces, such as the outer membrane, the periplasmic space and the inner membrane to load other substance. BG also can be used as DNA, antigen and drugs delivery vector as it exhibits potency with regard to target antigens and large capacity compared to conventional approaches. In addition, BG can be provided with a foreign antigen, nucleic acid or other ingredients to construct combined vaccine for human or animal health services. BG has wide application prospect in the prevention and treatment of disease.



Key wordsBacterial ghost      Vaccine      Delivery vector     
Received: 08 July 2014      Published: 25 September 2014
ZTFLH:  Q78  
Cite this article:

YANG Hui, JIAO Hong-mei. Advances on Bacterial Ghost as Novel Vaccine and Delivery Vector. China Biotechnology, 2014, 34(9): 108-112.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20140916     OR     https://manu60.magtech.com.cn/biotech/Y2014/V34/I9/108


[1] Witte A, Wanner G, Sulzner M, et al. Dynamics of PhiX174 protein E-mediated lysis of Escherichia coli. Arch Microbiol, 1992, 157 (4): 381-388.

[2] 李小姝,马跃,李安兴,等. 禽致病性大肠杆菌(APEC) 菌蜕的制备研究.中国预防兽医学报,2007,29 (6): 423-427. Li X M,Ma Y,Li A X,et al. Generation of avian pathogenic E.coli ghosts.Chinese Journal of Preventive Veterinary Medicine, 2007,29 (6): 423-427.

[3] Ulrike B M, Petra W, Chakameh A,et al. Bacterial ghosts as antigen delivery vehicles. Advanced Drug Delivery Reviews, 2005, 57 (9) : 1381-1391.

[4] Jechlinger W, Szostak M P, Witte A, et al. Altered temperature induction sensitivity of the lambda pR/cI857 system for controlled gene E expression in Escherichia coli. FEMS Microbiol Lett,1999, 173 (2): 347-352.

[5] 徐良,李媛,魏延宏,等.利用双基因裂解系统制备大肠杆菌菌影的裂解效果评价.黑龙江畜牧兽医,2013, 3 (5):14-16. Xu L, Li Y, Wei H Y,et al.Evaluation of the lysis effect for the preparation of Escherichia coli ghosts withthe two-gene lysis system.Heilongjiang Animal Science and Veterinary Medicine,2013,3(5):14-16.

[6] Seung J P, Seok-J L, Kim Ki-Hong, et al. High cell density fed-batch fermentation for the production of recombinant E.coli K-12 ghost vaccine against streptococcal disease. Biotechnology and Bioprocess Engineering, 2011, 16 (4): 733-738.

[7] 胡本钢.应用抗菌肽-超高压制备肺炎克雷伯菌和副猪嗜血杆菌菌影方法的建立.吉林:吉林大学,2012. Hu B G.Establishment of a Novel Preparation Method for KlebsiellaPneumoniae and Haemophilus parasuisGhosts by Antimicrobial Peptide and Ultrahigh Pressure.Jilin:Jilin University, 2012.

[8] Amara A A, Salem-Bekhit Mounir M, Alanazi Fars K.Sponge-Like: a new protocol for preparing bacterial ghosts.The Scientific World Journal, 2013, Article ID 545741, 7 pages.

[9] Haidinger W, Mayr U B, Szostak M P, et al. Escherichia coli ghost production by expression of lysis gene E and staphylococcal nuclease. Applied and Environmental Microbiology, 2003, 69 (10): 6106-6113.

[10] Eko F O, Schukovskaya T, Lotzmanova E Y, et al. Evaluation of the protective efficacy of vibrio cholerae ghost(VCG)candidate vaccines in rabbits. Vaccine,2003, 21(25-26): 3663-3674.

[11] Marchart J, Rehagen M, Dropmann G, et al. Protective immunity against pasteurel losis in cattle induced by pasteurella haemolytica ghosts. Vaccine, 2003, 21 (13-14): 1415-1422.

[12] Marchart J, Dropmann G, Lechleitne S, et al. Pasteurella multocida and Pasteurell multocida ghosts new vaccine candidates. Vaccine, 2003, 21 (25-26): 3988-3997.

[13] 杜崇涛,李林溪,雷连成等.猪胸膜肺炎放线杆菌菌影的制备与免疫试验.中国兽医学报, 2012, 32 (10) : 1461-1466. Du CH T, Li L X, Lei L C.Preparation and experimental immunity of Actinobacillus pleuropneumoniae ghost vaccine.Chinese Journal of Veterinary Science,2012, 32 (10) : 1461-1466.

[14] Zhu W X, Yang G W, Zhang Y Y, et al. Generation of biotechnology-derived Flavobacterium columnare ghosts by PhiX174 gene E-mediated inactivation and the potential as vaccine candidates against infection in grass carp. Journal of Biomedicine and Biotechnology, 2012, 2012:760730 doi:10.1155/2012/760730.

[15] Hu M, Zhang Y, Xie F, et al. Protection of piglets by a Haemophilus parasuis ghost vaccine against homologous challenge.Clinical and Vaccine Immunology, 2013, 20 (6):795-802.

[16] Nagarajan V, Sung O, Seongdae K et al. Chemically induced Salmonella enteritidis ghosts as a novel vaccine candidate against virulent challenge in a rat model. Vaccine, 2014, 32 (26): 3249 -3255.

[17] Vilte D A, Larzábal M, Mayr U B, et al. A systemic vaccine based on Escherichia coli O157:H7 bacterial ghosts (BGs) reduce the excretion of E. coli O157:H7 in calves.Veterinary Immunology and Immunopathology, 2012,146 (2012):169-176.

[18] Cai K, Zhang Y, Yang B Y, et al. Yersinia enterocolitica ghost with msbB mutation provides protection and reduces proinflammatory cytokines in mice.Vaccine, 2013, 31 (2) : 334-340.

[19] Kudela P, Paukner S, Mayr UB, et al. Effective gene transfer to melanoma cells using bacterial ghosts. Cancer Letters, 2008, 262 (1): 54-63.

[20] Paukner S, Kudela P, Kohl G, et al. DNA-loaded bacterial ghosts efficiently mediate reporter gene transfer and expression in macrophages. Molecular Therapy, 2005, 11 (2): 215-223.

[21] Ebensen T, Paukner S, Link C, et al. Bacterial ghosts are an efficient delivery system for DNA vaccines. Journal Immunology, 2004, 172 (11): 6858-6865.

[22] Wen J, Yang Y, Zhao G, et al. Salmonella typhi Ty21a bacterial ghost vector augments HIV-1 gp140 DNA vaccine-induced peripheral and mucosal antibody responses via TLR4 pathway. Vaccine, 2012, 30 (39): 5733-5739.

[23] Eko F O, Okenu D N, Singh U P, et al. Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate.Vaccine,2011, 29(21): 3802-3810.

[24] Jechlinger W,Haller C,Resch S,et.al.Comparative immunogenicity of the hepatitis B virus core 149 antigen displayed on the inner and outer membrane of bacterial ghosts. Vaccine, 2005,23 (27) : 3609 -3617.

[25] Talebkhan Y, Bababeik M, Esmaeili M, et al. Helicobacter pylori bacterial ghost containing recombinant Omp18 as a putative vaccine. Journal of Microbiological Methods,2010, 82 (3): 334-337.

[26] 徐良,猪传染性胸膜肺炎放线杆菌菌影装载猪源巴氏杆菌外膜蛋白H基因疫苗的免疫效果评价.天津:天津农学院,2013. Xu L. Evaluation of Immunological Effectives ofActinobacillus pleuropneumoniae Bacterial Ghost Loaded with Pasteurella Multocida OomphGene Vaccine. Tianjin:Tianjin Agricultural University,2013.

[27] 张瑞平, 张兆山. 细菌菌蜕作为新颖药物递送体系的研究进展. 生物化学与生物物理进展, 2006, 33 (7): 622-626.

[28] Susanne P, Gudrun K, Werner L. Bacterial ghosts as novel advanced drug delivery systems: anti-proliferative activity of loaded doxorubicin in human Caco-2 cells. Journal of Controlled Release, 2004, 94 (1) : 63-74.

[29] Pavol K, Verena J K, Ulrike B M, et al. Bacterial Ghosts as antigen and drug delivery system for ocular surface diseases: Effective internalization of bacterial ghosts by human conjunctival epithelial cells. Journal of Biotechnology, 2011,153 (3-4) :167-175.

[1] XIAO Yun-xi,ZHANG Jun-he,YANG Wen-wen,CHENG Hong-wei. Research Progress of Human Diploid Cells for Vaccine Production[J]. China Biotechnology, 2021, 41(11): 74-81.
[2] ZHU Xiao-jing,WANG Rui,ZHANG Xin-xin,JIN Jia-xin,LU Wen-long,DING Da-shun,HUO Cui-mei,LI Qing-mei,SUN Ai-jun,ZHUANG Guo-qing. Construction of MDV Recombinant Vaccine Strain Integrated F Gene Using Bacterial Artificial Chromosome Technique[J]. China Biotechnology, 2021, 41(10): 33-41.
[3] CHENG Xu,YANG Yu-qing,WU Sai-nan,HOU Qin-long,LI Yong-mei,HAN Hui-ming. Construction of DNA Vaccines of Staphylococcus aureus SarA, IcaA and Their Fusion Genes and Preliminary Study in Mouse Immune Response[J]. China Biotechnology, 2020, 40(7): 41-50.
[4] LIU Zhen-zhen,TIAN Da-yong. Development of Sucrose Density Gradient Centrifugation Purification Process for Rabies Vaccine[J]. China Biotechnology, 2020, 40(4): 25-33.
[5] QIAN Ying,QIAN Chen,BAI Xiao-qing,WANG Jing-jing. Application of Adjuvant in Cancer Immunotherapy[J]. China Biotechnology, 2020, 40(3): 96-103.
[6] XIE Hua-ling,LV Lu-cheng,YANG Yan-ping. Patent Analysis of Global Coronavirus Vaccine[J]. China Biotechnology, 2020, 40(1-2): 57-64.
[7] JING Hui-yuan,DUAN Er-zhen,DONG Wang. In Vitro Transcribed Self-amplifying mRNA Vaccines[J]. China Biotechnology, 2020, 40(12): 25-30.
[8] LIAO Xiao-yan,CHEN Li-li. The Progress in the Development of COVID-19 Vaccine[J]. China Biotechnology, 2020, 40(12): 8-17.
[9] FENG Xue-jiao,HOU Hai-long,YU Qiong,WANG Jun-shu. Market Analysis and Countermeasures of Cervical Cancer Vaccine in China[J]. China Biotechnology, 2020, 40(11): 96-101.
[10] Yan GAO,Jing-jing DU,Bin WANG,Qi LIU,Zhi-qiang SHEN. Study on β-Propiolactone in Inactivation Process of Rabies Vaccine by Gas Chromatography[J]. China Biotechnology, 2019, 39(6): 25-31.
[11] Lin YANG,Zhe-yan FU,Zheng-bing LV,Jian-hong SHU. Classification and Mechanism of Immune Adjuvant[J]. China Biotechnology, 2019, 39(5): 114-119.
[12] Jia-yue XU,Zi-qian LI,Ge ZHANG. Advanced in Research Dengue Virus 3'UTRΔ30 Series Vaccines[J]. China Biotechnology, 2019, 39(3): 97-104.
[13] Fu-lan GAO,Jia-long QI,Cong-yan SHU,Hang-hang XIE,Wei-wei HUANG,Cun-bao LIU,Xu YANG,Wen-jia SUN,Hong-mei BAI,Yan-bing MA. Efficient Secretory Expression of Optimized Mouse Interleukin-33 Gene in Mammalian Cells[J]. China Biotechnology, 2019, 39(3): 46-55.
[14] Xi-wen JIANG,Zi-wei DONG,Yue LIU,Xiao-ya ZHU. Reserch Progress on Biomarkers and Precision Medicine[J]. China Biotechnology, 2019, 39(2): 74-81.
[15] SUN Si,QIU Yu-lan,YAN Ju-rong,YANG Jing,WU Guang-ying,WANG Lin,XU Wen-chun. Recombinant Plasmid pcDNA3-dnaJ Prime/DnaJ Protein Boost Immunization Induce Th1/Th17 Immune Responses and Protect Mice Against Pneumococcal Infection[J]. China Biotechnology, 2019, 39(12): 9-17.